Pasithea Therapeutics Corp.

NasdaqCM:KTTA Stock Report

Market Cap: US$25.3m

Pasithea Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:KTTA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Nov 25BuyUS$25,000Tiago MarquesIndividual33,333US$0.75
28 Nov 25BuyUS$25,000Simon DumesnilIndividual33,333US$0.75
28 Nov 25BuyUS$100,000Lawrence SteinmanIndividual133,333US$0.75
12 May 25SellUS$792Tiago MarquesIndividual960US$0.82

Insider Trading Volume

Insider Buying: KTTA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KTTA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders372,3581.66%
Institutions1,117,1934.99%
General Public20,909,36993.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1668.7%.

Top Shareholders

Top 25 shareholders own 6.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.62%
Orca Capital GmbH
362,857US$410.0k0%5.06%
1.15%
AdvisorShares Investments, LLC
257,696US$291.2k33.1%0.04%
0.89%
Lawrence Steinman
199,691US$225.7k201%no data
0.63%
Armistice Capital LLC
142,082US$160.6k0%no data
0.33%
Tiago Marques
73,334US$82.9k83.3%no data
0.3%
Citadel Advisors LLC
67,341US$76.1k43.7%no data
0.24%
The Vanguard Group, Inc.
53,815US$60.8k0%no data
0.16%
Simon Dumesnil
35,833US$40.5k1,330%no data
0.16%
Two Sigma Investments, LP
35,760US$40.4k0%no data
0.15%
XTX Markets Limited
34,358US$38.8k0%no data
0.15%
Emer Leahy
33,333US$37.7k0%no data
0.14%
Renaissance Technologies LLC
30,700US$34.7k0%no data
0.12%
Daniel Schneiderman
26,667US$30.1k0%no data
0.11%
Geode Capital Management, LLC
25,475US$28.8k307%no data
0.11%
Virtu Financial, Inc.
25,075US$28.3k0%no data
0.11%
Jane Street Group, LLC
25,053US$28.3k0%no data
0.093%
Two Sigma Securities, LLC
20,846US$23.6k0%no data
0.082%
UBS Asset Management AG
18,381US$20.8k-56.4%no data
0.049%
Hudson River Trading LLC
10,896US$12.3k0%no data
0.016%
Hurley Capital, LLC
3,689US$4.2k0%no data
0.016%
Alfred Novak
3,500US$4.0k0%no data
0.0054%
Tower Research Capital Europe Limited
1,217US$1.4k-3.49%no data
0.0047%
SBI Holdings, Inc.
1,051US$1.2k0%no data
0.002%
Citigroup Inc.
443US$501.20%no data
0.0011%
RBC Dominion Securities Inc.
250US$283.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/07 03:57
End of Day Share Price 2025/12/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pasithea Therapeutics Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Constantine DavidesD. Boral Capital LLC.